Pfizer works to lower manufacturing costs

"Profitability comes from low-cost manufacturing," says Jean-Michel Halfon, Pfizer president for emerging markets. "Low-cost solutions developed in emerging markets could be useful everywhere. We're working on it." Article


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.